Abstract

Liothyronine Sodium (T3) 5-mcg/Selenium 100-mcg Slow-Release Capsules

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2008 - Arthritis and Immunological Diseases

Page(s): 547

Download in electronic PDF format for $75

Abstract

A formulation for preparing Liothyronine Sodium (T3) 5-mcg/Selenium 100-mcg Slow-Release Capsules. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Nov/Dec 2008 Pg. 547	Liothyronine Sodium (T3) 5-mcg/Selenium 100-mcg Slow-Release Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 548	Liothyronine Sodium (T3) 5-mcg Slow-Release Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 545	Liothyronine Sodium (T3) 5-mcg/Hydrocortisone 5-mg Slow-Release Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 418-425	Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3) Author(s): Bakhteyar Hamid, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
Nov/Dec 2008 Pg. 546	Liothyronine Sodium (T3) 5-mcg/0.1-mL Transdermal Cream Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 376-380	Bioidentical Thyroid Replacement Therapy in Practice: Delivering a Physiologic T4-T3 Ratio for Improved Patient Outcomes with the Listecki-Snyder Protocol Author(s): Snyder Scott, Listecki Robert E
Jul/Aug 2005 Pg. 268-273	Hypothyroidism: Optimizing Therapy with Slow-Release Compounded Thyroid Replacement Author(s): Milner Martin
Jul/Aug 2010 Pg. 306-309	Thyroid Potency Calculations Author(s): Stack Bob
Nov/Dec 2013 Pg. 505	Levothyroxine Sodium 100-mcg Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 149	Selenium 40-mcg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 10-22	Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients Author(s): Zur Eyal
Sep/Oct 2001 Pg. 401-405	Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release Author(s): Bogner Robin H, Szwejkowski Jessica, Houston Alana
Jan/Feb 2024 Pg. 34-43	Differentiation and Treatment of Hypothyroidism, Functional Hypothyroidism, and Functional Metabolism Author(s): Paoletti Jim
Nov/Dec 2008 Pg. 488-497	Differentiation and Treatment of Hypothyroidism, Functional Hypothyroidism, and Functional Metabolism Author(s): Paoletti Jim
Jan/Feb 2017 Pg. 39-45	Basics of Compounding with Dilutions and Concentrates Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 22-23	The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone Author(s): Brunner Scott
Jan/Feb 2020 Pg. 62	Progesterone 100-mg, Melatonin 1-mg, and L-Theanine 200-mg Slow-Release Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 434-437	Compounding of Slow-release Niacinamide Capsules: Feasibility and Characterization Author(s): Radojkovic Branko, Milic Jela, Calija Bojan
Mar/Apr 2005 Pg. 157-164	In Vitro Evaluation of Extemporaneously Compounded Slow-Release Capsules Containing Morphine Sulfate or Oxycodone Hydrochloride Author(s): Glowiak Dana L, Green Julie L, Bowman Bill J
Jan/Feb 2001 Pg. 52-54	Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2 Author(s): Ford Gina, Garcia Lea